Advocacy intelligence hub — real-time data for patient organizations
Assistance Publique - Hôpitaux de Paris — NA
University of Ulm
University Ghent — NA
Rhythm Pharmaceuticals, Inc. — PHASE1, PHASE2
Fudan University — NA
Nationwide Children's Hospital — PHASE1, PHASE2
Institute of Cardiometabolism and Nutrition, France
Children's Hospital Medical Center, Cincinnati
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
LISDEXAMFETAMINE DIMESYLATE
Camber Pharmaceuticals, Inc.
LISDEXAMFETAMINE DIMESYLATE
(LISDEXAMFETAMINE DIMESYLATE)standardCamber Pharmaceuticals, Inc.
12.1 Mechanism of Action Lisdexamfetamine is a prodrug of dextroamphetamine. Amphetamines are non-catecholamine sympathomimetic amines with CNS stimul...
Merlin G Butler, MD, M.D., Ph.D
Children's Mercy Hospital Kansas City
📍 KANSAS CITY, KS
Maithe TAUBER, MD
Hospital of Toulouse
Jessica Duis, MD, MS, M.D
Children's Hospital Colorado
📍 AURORA, CO
Deepan Singh, MD, M.D
Maimonides Medical Center
📍 GLEN OAKS, NY
Lynne M. Bird, MD, RN
Division of Dysmorphology/Genetics, Children's Hospital San Diego, Department of Pediatrics, University of California, San Diego
📍 GRAND JUNCTION, CO
Carlos A. Bacino, MD, MD
Department of Molecular and Human Genetics, Baylor College of Medicine
📍 HOUSTON, TX